...
首页> 外文期刊>Pregnancy hypertension >Prospective biomarkers in preterm preeclampsia: A review
【24h】

Prospective biomarkers in preterm preeclampsia: A review

机译:前瞻性生物标志物在早产预口普拉姆斯:审查

获取原文
获取原文并翻译 | 示例
           

摘要

Preterm pre-eclampsia (prior to 37 weeks' gestation) remains a major cause of maternal and fetal morbidity and mortality particularly in low to middle income countries. Much research has focused on first and second trimester predictors of pre-eclampsia with the aim of allowing stratification of antenatal care and trialling of potential preventative and therapeutic agents. However, none have been shown to be of benefit in randomised controlled trials.
机译:早产预葛兰普查(在37周之前的妊娠之前)仍然是孕产妇和胎儿发病率和死亡率的主要原因,特别是低到中等收入国家。 许多研究专注于先兆子痫的第一和第二三月预测因子,目的是允许产前护理和潜在预防和治疗剂的试验分层。 但是,没有任何已显示在随机对照试验中有益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号